s6y
Company name or ticker
Search
AEON Biopharma, Inc.
4
LYNCH TIMOTHY P: Statement of changes in beneficial ownership of securities
Filed
Friday, August 21, 2026
Period
Aug 19, 2026
Accession number
0000935836-26-000440
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header